Quality control in flow cytometry

Flow Cytometry: Principles and Applications

Volumn , Issue , 2007, Pages 113-131

  Barnett, David ^a   Reilly, John T ^a  

^a UK NEQAS   (United Kingdom)

Author keywords

Cell enumeration; control beads; internal and external quality assurance

Indexed keywords

EID: 84920165141     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59745-451-3_4     Document Type: Chapter

References (69)

1. Schwartz, A., Marti, G. E., Poon, R., Gratama, J. W., and Fernández-Repollet, E. (1998) Standardizing flow cytometry: A classification system of fluorescence standards used for flow cytometry. Cytometry 33, 106-114.
2. +stem and progenitor cells by flow cytometry - Time to let go! Cytometry 34, 280-283.
3. San Miguel, J. F., Martínez, A., Macedo, A., et al. (1997) Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients. Blood 90, 2465-2470.
4. Barnett, D., Granger, V., Mayr, P., Storie, I., Wilson, G.A., and Reilly, J. T. (1996) Evaluation of a novel stable whole blood quality control material for lymphocyte subset analysis: results from the UK NEQAS Immune Monitoring Scheme. Cytometry 26, 216-222.
5. Fay, S. P., Barnett, D., Granger, V., and Mercolino, T. (1994) Absolute control - A novel stabilized whole blood preparation for leucocyte immunophenotyping full process control. Cytometry 18, 177 (Abstract).
6. Bergeron, M., Faucher, S., Minkus, T., et al. (1998) Impact of unified procedures as implemented in the Canadian quality assurance program for T lymphocyte subset enumeration. Cytometry 33, 146-155.
7. Ekong, T., Kupek, E., Hill, A., Clark, C., Davies, A., and Pinching, A. (1993) Technical influences on immunophenotyping by flow cytometry. The effect of time and temperature of storage on the viability of lymphocyte subsets [published erratum appears in J. Immunol. Methods 1993 Dec 3;166(2):301]. J. Immunol. Methods 164, 263-273.
8. +T lymphocytes in immunosuppressed individuals. Clin. Lab. Haematol. 19, 231-241.
9. Borowitz, M. J., Bray, R., Gascoyne, R., et al. (1997) US-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data analysis and interpretation. Cytometry 30, 236-244.
10. Nicholson, J. K. A. (1994) Immunophenotyping specimens from HIV-infected persons: laboratory guidelines from the Centers for Disease Control and Prevention. Cytometry 18, 55-59.
11. +cell determination by flow cytometry. J. Hematother. 5, 213-226.
12. Romeu, M. A., Mestre, M., Gonzalez, L., et al. (1992) Lymphocyte immunophenotyping by flow cytometry in normal adults. Comparison of fresh whole blood lysis technique, Ficoll-Paque separation and cryopreservation. J. Immunol. Methods 154, 7-10.
13. +cell counting in phosphate-buffered saline-diluted leukapheresis samples. Cytometry 43, 154-160.
14. Gratama, J. W., van der Linden, R., Van der Holt, B., Bolhuis, R. L., and Van de Winkel, J.G. (1997) Analysis of factors contributing to the formation of mononuclear cell aggregates ("escapees") in flow cytometric immunophenotyping. Cytometry 29, 250-260.
15. Kromer, E. and Grossmuller, F. (1994) Light scatter based lymphocyte gate-helpful tool or source of error? Cytometry 15, 87-89.
16. Loken, M. R., Brosnan, J. M., Bach, B. A., and Ault, K. A. (1990) Quality control in flow cytometry: 1.: Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry. Cytometry 11, 453-459.
17. +T-cell enumeration. Cytometry 30, 157-165.
18. Mandy, F. F., Bergeron, M., Recktenwald, D., and Izaguirre, C.A. (1992) A simultaneous three-color T cell subsets analysis with single laser flow cytometers using T cell gating protocol. Comparison with conventional two-color immunophenotyping method. J. Immunol. Methods 156, 151-162.
19. +T-cell enumeration. Cytometry 50, 69-77.
20. Siena, S., Bregni, M., Brando, B., et al. (1991) Flow cytometry for the clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 77, 400-409.
21. +cells by flow cytometry: Application to the harvesting and transplantation of peripheral blood stem cells, in Hematopoietic Stem Cells: The Mulhouse Manual (Wunder, E., Sovalat, H., Henon, P., and Serke, S., eds.), AlphaMed Press, Dayton, Ohio, p. 31.
22. +hematopoietic progenitor cell enumeration in a multicenter study. Cytometry 30, 109-117.
23. +stem cell enumeration: experience of the United Kingdom National External Quality Assessment Scheme (UK NEQAS) using a unique stable whole blood preparation. Br. J. Haematol. 102, 553-565.
24. +cell counts based on the ISHAGE guidelines. Cytometry 34, 61-70.
25. Keeney, M., Brown, W., Gratama, J., et al. (2003) Single platform enumeration of viable CD34(pos) cells. J. Biol. Regul. Homeost. Agents 17, 247-253.
26. Verwer, B. J. H. and Ward, D. M. (1997) An automated classification algorithm for ProCount flow cytometric acquisition and analysis. J. Hematother. 6, 169 (Abstract).
27. +hematopoietic stem and progenitor cells. Cytometry 34, 128-142.
28. +cell quantitation: An Australian multi-centre study. J. Hematother. 5, 605-616.
29. +stem cell enumeration by the use of stable test material, standard protocols and targeted training. Br. J. Haematol. 108, 784-792.
30. +hematopoietic stem and progenitor cell enumeration in an international multicenter study. Cytotherapy 5, 55-65.
31. O'Gorman, M. R. and Thomas, J. (1999) Isotype controls-time to let go? Cytometry 38, 78-80.
32. +enumeration (response to Letter to the Editor). J. Hematother. 6, 85-89.
33. Ratei, R., Karawajew, L., Lacombe, F., et al. (2006) Normal lymphocytes from leukemic samples as an internal quality control for fluorescence intensity in immunophenotyping of acute leukemias. Cytometry B Clin. Cytom. 70, 1-9.
34. Owens, M. A. and Loken, M. R. (1995) Flow Cytometry Principles for Clinical Laboratory Practice: Quality Assurance for Quantitative Immunophenotyping, Wiley-Liss, Inc., New York pp. 129-154.
35. +cell enumeration in blood and leukapheresis products: report from the second Nordic workshop. J. Hematother. 5, 237-245.
36. Lowdell, M. A. and Bainbridge, D. R. (1996) External Quality Assurance for CD34 cell enumeration - results of a preliminary national trial. Bone Marrow Transplant. 17, 849-853.
37. +cell estimation in leucapheresis products. Bone Marrow Transplant. 18, 791-796.
38. Paxton, H., Kidd, P., Landay, A., et al. (1989) Results of the flow cytometry ACTG quality control program: Analysis and findings. Clin. Immunol. Immunopathol. 52, 68-84.
39. Forrest, M. J. and Barnett, D. (1989) Laboratory control of immunocytochemistry. Eur. J. Haematol. 42, 67-71.
40. Storr, J., Dolan, G., Coustan-Smith, E., Barnett, D., and Reilly, J. T. (1990) Value of monoclonal anti-myeloperoxidase (MPO7) for diagnosing acute leukaemia. J. Clin. Pathol. 43, 847-849.
41. British Committee for Standardisation of Haematology (General Haematology Task Force). (1994) Immunophenotyping in the diagnosis of acute leukaemias. J. Clin. Pathol. 47, 777-781.
42. British Committee for Standardisation of Haematology (General Haematology Task Force). (1994) Immunophenotyping in the diagnosis of chronic lymphoproliferative disorders. J. Clin. Pathol. 47, 871-875.
43. Bain B., Barnett D., Linch D., Matutes E., and Reilly, J. T.; General Haematology Task Force of the British Committee for Standards in Haematology (BCSH), British Society of Haematology. (2002) Revised guideline on immunophenotyping in acute leukaemias and chronic lymphoproliferative disorders. Clin. Lab. Haematol. 24, 1-13.
44. Civin, C. I., Trischmann, T. M., Fackler, M. J., et al. (1989) Report on the CD34 Cluster Workshop, in Leucocyte Typing IV: White Cell Differentiation Antigens (Knapp, W., Dorken, B., Gilks, W. R., Rieber, E. P., Schmidt, R. E., Stein, H., and von dem Borne, A. E. G. Kr., eds.), Oxford University Press, Oxford, p. 818.
45. Simmons, P. J. and Torok-Storb, B. (1991) CD34 expression by stromal precursors in normal human adult bone marrow. Blood 78, 2848-2853.
46. Terstappen, L. W., Gandour, D., Huang, S., et al. (1993) Assessment of hematopoietic cell differentiation by multidimensional flow cytometry. J. Hematother. 2, 431-447.
47. Sutherland, D. R. and Keating, A. (1992) The CD34 antigen: structure, biology and potential clinical applications. J. Hematother. 1, 115-129.
48. Sutherland, D. R., Marsh, J. C. W., and Davidson, J. (1992) Differential sensitivity of CD34 epitopes to cleavage by Pasteurella haemolytica glycoprotease: implications for purification of CD34-positive progenitor cells. Exp. Hematol. 20, 590-599.
49. Titley, I., Healy, L. E., and Gordon, M. Y. (1997) CD34 epitope expression on haemopoietic tissues. Br. J. Haematol. 98, 779.
50. Basso, G., Putti, M. C., Cantú-Rajnoldi, A., et al. (1992) The immunophenotype in infant acute lymphoblastic leukaemia: correlation with clinical outcome. An Italian multicentre study (AIEOP). Br. J. Haematol. 81, 184-191.
51. Cantú-Rajnoldi, A., Putti, C., Siatta, M., et al. (1991) Co-expression of myeloid antigens in childhood acute lymphoblastic leukaemia: relationship with stage of differentiation and clinical significance. Br. J. Haematol. 79, 40-43.
52. Fink, F. M., Koller, U., Mayer, H., et al. (1993) Prognostic significance of myeloidassociated antigen expression on blast cells in children with acute lymphoblastic leukemia. The Austrian Pediatric Oncology Group. Med. Pediatr. Oncol. 21, 340-346.
53. Piu, C.-H., Raimondi, S. C., Head, D. R., et al. (1991) Characterisation of childhood acute leukaemia with multiple myeloid and lymphoid markers at diagnosis and relapse. Blood 78, 1327-1337.
54. Piu, C.-H., Behm, F. G., Singh, B., et al. (1990) Myeloid-asociated antigen expression lacks prognostic value in childhood acute lymphoblastic leukaemia treated with intensive multiagent chemotherapy. Blood 75, 198-202.
55. Howard, M. R., Thomas, L., and Reid, M. M. (1994) Variable detection of myeloid antigens in childhood acute lymphoblastic leukaemia. J. Clin. Pathol. 47, 1006-1009.
56. Molica, S., Dattilo, A., and Albert, A. (1991) Myelomonocytic antigens in B-chronic lymphocytic leukaemia: Analysis of clinical significance. Leuk. Lymphoma 5, 139-144.
57. Polliack, A., Rabinowitz, R., Leizerowitz, R., Keren-zur, Y., and Schlesinger, M. (1993) Myelomonocytic antigens are rarely expressed on B-lymphocytic leukaemia cells. Leuk. Lymphoma 9, 125-131.
58. Morabito, F., Prasthofer, E. F., Dunlap, N.E., Grossi, C. E., and Tielden, A. B. (1987) Expression of myelomonocytic anigens on chronic lymphatic leukaemia B cells correlates with their ability to produce interleukin-1. Blood 70, 1750-1757.
59. Pinto, A., Zagonel, V., Carbone, A., et al. (1992) CD13 expression in B-cell chronic lymphocytic leukaemia is associated with the pattern of bone marrow infiltration. Leuk. Lymphoma 6, 209-218.
60. Shapiro, H. M. (1997) Practical Flow Cytometry, Wiley-Liss, New York.
61. Reilly, J. T., Granger, V., Temperton, P. F., and Barnett, D. (1995) Leukaemia immunophenotyping: effect of antibody source and fluorochrome on antigen detection. J. Clin. Pathol. 48, 186.
62. Reilly, J. T. (1996) Use and evaluation of leucocyte monoclonal antibodies in the diagnostic laboratory: A review. Clin. Lab. Haematol. 18, 1-6.
63. Barnett, D., Storie, I., Wilson, G.A., Granger, V., and Reilly, J. T. (1998) Determination of leucocyte antibody binding capacity (ABC): The need for standardization. Clin. Lab. Haematol. 20, 155-164.
64. Campana, D. (1994) Applications of cytometry to study acute leukemia: in vitro determination of drug sensitivity and detection of minimal residual disease. Cytometry 18, 68-74.
65. British Committee for Standardisation of Haematology (Blood Transfusion Task Force). (1998) Guidelines on the clinical use of leucocyte-depleted blood components. Transfus. Med. 8, 59-71.
66. Robinson, G., Morgan, L., Evans, M., et al. (1992) Effect of type of haematology analyser on CD4 count. Lancet 340, 485-486.
67. Mercolino, T. J., Connelly, M. C., Meyer, E. J., et al. (1995) Immunologic differentiation of absolute count with an integrated flow cytometric system: A new concept for absolute T cell subset determinations. Cytometry 22, 48-59.
68. +T-lymphocyte evaluations based on acceptable data boundaries defined by the measurement error. Cytometry 50, 117-126.
69. + stem cell counts by single platform flow cytometry: The way forward. Br. J. Haematol. 106, 1059-1062.